On November 20, 2023, Dyne Therapeutics Inc (NASDAQ: DYN) opened at $11.02, lower -3.36% from the last session. During the day, the shares moved up to $11.45 and dropped to $10.52 before settling in for the closing price of $11.02. Price fluctuations for DYN have ranged from $6.40 to $15.60 over the past 52 weeks.
Company’s average yearly earnings per share was noted -16.59% at the time writing. With a float of $31.26 million, this company’s outstanding shares have now reached $55.64 million.
The firm has a total of 123 workers. Let’s measure their productivity.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 49.08%, while institutional ownership is 61.37%. The most recent insider transaction that took place on Nov 02, was worth 73,549. In this transaction Chief Operating Officer of this company sold 9,939 shares at a rate of $7.40, taking the stock ownership to the 94,605 shares. Before that another transaction happened on Sep 18, when Company’s insider sold 12,032 for $9.41, making the entire transaction worth $113,221. This insider now owns 233,679 shares in total.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.99 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.83) by -$0.16. This company achieved a return on equity of -54.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.59% per share during the next fiscal year.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 5.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Analysing the last 5-days average volume posted by the [Dyne Therapeutics Inc, DYN], we can find that recorded value of 0.8 million was better than the volume posted last year of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 75.03%. Additionally, its Average True Range was 0.89.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 67.68%, which indicates a significant decrease from 82.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.46% in the past 14 days, which was higher than the 86.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.58, while its 200-day Moving Average is $11.06. Now, the first resistance to watch is $11.23. This is followed by the second major resistance level at $11.80. The third major resistance level sits at $12.16. If the price goes on to break the first support level at $10.30, it is likely to go to the next support level at $9.94. Now, if the price goes above the second support level, the third support stands at $9.37.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 61,376K shares outstanding in the company with a market cap of 653.70 million. Presently, the company’s annual sales total 0 K according to its annual income of -168,100 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -60,210 K.